305 related articles for article (PubMed ID: 18050057)
1. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
[TBL] [Abstract][Full Text] [Related]
2. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T
Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry.
Stübiger G; Marchetti M; Nagano M; Reichel C; Gmeiner G; Allmaier G
Rapid Commun Mass Spectrom; 2005; 19(5):728-42. PubMed ID: 15700237
[TBL] [Abstract][Full Text] [Related]
4. Applications and biomonitoring issues of recombinant erythropoietins for doping control.
Tsitsimpikou C; Kouretas D; Tsarouhas K; Fitch K; Spandidos DA; Tsatsakis A
Ther Drug Monit; 2011 Feb; 33(1):3-13. PubMed ID: 21099742
[TBL] [Abstract][Full Text] [Related]
5. How to confirm C.E.R.A. doping in athletes' blood?
Leuenberger N; Lamon S; Robinson N; Giraud S; Saugy M
Forensic Sci Int; 2011 Dec; 213(1-3):101-3. PubMed ID: 21889277
[TBL] [Abstract][Full Text] [Related]
6. Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin.
Voss S; Lüdke A; Romberg S; Schänzer E; Flenker U; deMarees M; Achtzehn S; Mester J; Schänzer W
Int J Sports Med; 2010 Jun; 31(6):367-71. PubMed ID: 20419620
[TBL] [Abstract][Full Text] [Related]
7. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
[TBL] [Abstract][Full Text] [Related]
8. Identification of zinc-alpha-2-glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS.
Reichel C
J Mass Spectrom; 2008 Jul; 43(7):916-23. PubMed ID: 18576436
[TBL] [Abstract][Full Text] [Related]
9. Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis.
Lasne F; Thioulouse J; Martin L; de Ceaurriz J
Electrophoresis; 2007 Jun; 28(12):1875-81. PubMed ID: 17503402
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues.
Dehnes Y; Lamon S; Lönnberg M
J Pharm Biomed Anal; 2010 Dec; 53(4):1028-32. PubMed ID: 20656433
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in doping testing for erythropoietin.
Reichel C
Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
[TBL] [Abstract][Full Text] [Related]
12. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
Leuenberger N; Saugy J; Mortensen RB; Schatz PJ; Giraud S; Saugy M
Forensic Sci Int; 2011 Dec; 213(1-3):15-9. PubMed ID: 21816551
[TBL] [Abstract][Full Text] [Related]
13. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
Desharnais P; Naud JF; Ayotte C
Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
[TBL] [Abstract][Full Text] [Related]
14. Testing for recombinant erythropoietin.
Delanghe JR; Bollen M; Beullens M
Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
[TBL] [Abstract][Full Text] [Related]
15. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
Dehnes Y; Shalina A; Myrvold L
Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
[TBL] [Abstract][Full Text] [Related]
16. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
Dehnes Y; Hemmersbach P
Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
[TBL] [Abstract][Full Text] [Related]
17. [Oxygen blood transport and doping].
Audran M; Connes P; Varlet-Marie E
Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
[TBL] [Abstract][Full Text] [Related]
18. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and analogs.
Reichel C; Gmeiner G
Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
[TBL] [Abstract][Full Text] [Related]
20. Differences in capillary electrophoresis profiles of urinary and recombinant erythropoietin.
De Frutos M; Cifuentes A; Diez-Masa JC
Electrophoresis; 2003 Feb; 24(4):678-80. PubMed ID: 12601737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
